[1] Rosell R, Danenberg K, Alberola V,et al. Ribonucleotide reductase messenger RNA expression and survival in Gemcitabine/Cisplatin-treated advanced non-small-cell lung cancer patients[J].Cli Cancer Res,2004,10(4):1318-1325. [2] Rosell R, Scagliotti G, Danenberg K,et al. Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer[J].Oncogene,2003,22(23):3548-3553. [3] De Laat WL,Jaspers NG,Hoeijmakers JH.Molecular mechanism of nucleotide excision repair[J].Genes Dev,1999,13(7):768-785. [4] 何朗,侯梅,徐聂.恶性肿瘤中ERCC1结构与功能的研究进展[J].现代预防医学,2009,36(19) :3733. [5] 张树生,谷永红.ERCC1与恶性肿瘤化疗疗效及预后的最新进展[J].实用预防医学,2010,17(4):817. [6] 徐风华,郭荣荣,李欣,等.非小细胞肺癌患者ERCC1表达与铂类药物化疗疗敏感性的相关性的系统分析[J].中国临床药理学与治疗学,2013,18(1):45-50. [7] 金艺凤,蒋静涵,黄群联,等. DNA修复基因多态性与非小细胞肺癌患者含铂方案化疗预后的关系[J].中国老年学杂志,2012,32(9):1810-1813. [8] Zhang ZY,Peng YJ. Relationship of BCL-2 with bone marrow angiogenesis in patients with acute leukemia [J]. Anti-tumor Pharmacy, 2011,1(6):8-11. [9] Zhong L, Yuan LM. The impact of Xuefu Zhuyu Decoction on the Expression of Estrogen Receptor and BCL-2 in Hysteromyoma[J]. Anti-tumor Pharmacy, 2012, 2(1): 34-36. [10] 古颖春,宋业林,张春玲,等.P53、Bcl-2、nm23蛋白质在肺癌中的表达及与预后的关系[J].山东医药,2011,51(13):54-55. [11] 张学林,余秉翔. Bcl2-siRNA提高人肺腺癌细胞A549/DDP对顺铂敏感性的研究[J].军医进修学院学报,2012,33(6):649-652. |